Financial Results / Presentation Materials FY2024

• Notice Regarding Revision of the Forecasts, Revision of the Dividend Forecasts, and Recording of Impairment Losses for the Consolidated Financial Results for the Fiscal Year ended March 31, 2023（579KB)
• Notice Regarding Revision of the Forecasts, Revision of the Dividend Forecasts, and Recording of Impairment Losses for the Consolidated Financial Results for the Fiscal Year ended March 31, 2023(with notes)（531KB)
• Q＆A（135KB）

Summary of Consolidated Financial Results

• Six months ended September 30, 2024 [IFRS] (412KB) [November 5, 2024]
• Six months ended September 30, 2024 [IFRS] [November 5, 2024] (HTML)

Financial Results Briefing Session

• Presentation Slides for Q2/March 2025 Consolidated Financial Results (1.7MB) [November 5, 2024]
• Supplementary Material for Q2/March 2025 Consolidated Financial Results (49KB) [November 5, 2024]
• Presentation Slides for Q2/March 2025 Consolidated Financial Results (with notes and Q&A) (2.9MB) [November 7, 2024]

Summary of Consolidated Financial Results

• Three Months Ended June 30, 2024 [IFRS] (391KB) [July 31, 2024]
• Three Months Ended June 30, 2024 [IFRS] (Completion of Interim Review by an Independent Auditor) (498KB)[August 9, 2024]
• Three Months Ended June 30, 2024 [IFRS] [July 31, 2024] (HTML)

Financial Results Briefing Session

• Presentation Slides for Q1/March 2025 Consolidated Financial Results (1.8MB) [July 31, 2024]
• Supplementary Material for Q1/March 2025 Consolidated Financial Results (46KB) [July 31, 2024]
• Presentation Slides for Q1/March 2025 Consolidated Financial Results (with notes and Q&A) (3.0MB) [August 5, 2024]